Xencor | XNCR - Ebit





Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 4.61B 777M 2026-06
Arrowhead Research USD -154.34M 13.08M 2026-06
AstraZeneca USD 3.16B 3.95B 2026-06
Biogen USD -243.8M 758.1M 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Cytokinetics USD -179.17M 2.05M 2026-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
J&J USD 7.48B 860M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
MacroGenics USD -31.88M 19.79M 2026-03
Merck USD 840M 2.72B 2026-06
Novartis USD 4.73B 549M 2026-06
Pfizer USD -180M 5.16B 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Xencor USD -36.6M 41.26M 2026-06